5-Hydroxytryptamine in the pathogenesis of affective disorders.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001792:Blood Platelets / Q000378:metabolism; D001923:Brain Chemistry; D004565:Electroconvulsive Therapy; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy; D012701:Serotonin / Q000097:blood / Q000134:cerebrospinal fluid / Q000502:physiology* / Q000652:urine
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008094:Lithium